Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment, today announced an expanded ...
Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...
Clinical Trials Arena on MSN
Clinical trial experts cite trust and regulatory uncertainty as AI barriers
The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London.
Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical ...
Pfizer Inc. (NYSE: PFE) and Innovent Biologics, Inc. (01801.HK), today announced the companies have entered into a strategic global licensing and collaboration agreement for the research and ...
We are delighted to receive this Horizon Europe grant, which is a further validation of both our scientific approach ...
ACT Brief: Clinical Development Orchestration, Career Insights in Trials, and FDA Communication Gaps
In today's ACT Brief, we examine how program-level orchestration is becoming critical to R&D success, reflections on ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH) (the “Company”), a leading global life sciences company, today announced that its Board of Directors has authorized the Company to pursue a ...
In a recent video interview with Applied Clinical Trials, Sam Hinsley, statistics manager at Phastar, discussed the critical ...
Brings more than 20 years of neurology, clinical development, and translational experience as AstronauTx prepares to advance its lead programmes into clinical developmentAstronauTx also appoints Deb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results